Taysha Gene Therapies Inc (TSHA)
R&D Expense Growth
14.28%
Quarterly · Period ending:
TSHA R&D Expense Growth
Latest reported14.28%period ending
Latest reported14.28%period ending
TSHA Quarterly R&D Growth (QoQ) (0.00% → 14.28%)
Latest values, visible window
High-resolution chart · PNG
TSHA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 14.2773% | |
| 37.1395% | |
| -3.1659% | |
| 26.4039% | |
| 29.3993% | |
| 1.5661% | |
| 2.5358% | |
| -0.8426% | |
| -27.032% | |
| 62.8844% | |
| 7.5566% | |
| -40.4224% | |
| 58.1509% | |
| -9.7179% | |
| -17.3662% | |
| -28.6395% | |
| -38.437% | |
| 0.6962% | |
| -4.0731% | |
| 28.9952% | |
| 28.4606% | |
| 94.5677% | |
| 10.88% | |
| 261.1039% | |
| -44.4686% | |
| 458.6626% | |
| 0% |